The TSC Alliance is collecting clinical information about individuals with TSC who were infected with COVID-19. Please circulate the following to your patients:
The American Epilepsy Society (AES) is proud to support established investigators working in basic, translational, and clinical research for epilepsy, seizures, and related disorders.
Are you looking for samples from TSC patients to use in your lab? The TSC Biosample Repository has a growing collection of samples tied to phenotypic data. In most cases, we can ship these samples at no charge to the investigator.
The TSC Alliance invites healthcare professionals affiliated with a TSC Clinic, TSC Center of Excellence, or University Medical Center to subscribe to our private listserv: email@example.com.
Mark you calendars now for the 2023 International TSC Research Conference, hosted by the TSC Alliance, scheduled for September 7-9, 2023 at the Omni Shoreham Hotel in Washington, DC. The conference will focus on structured, collaborative discussions on groundbreaking research topics.
The Simons Foundation is committed to supporting scientists as they transition from mentored training to their first independent research positions. To that end, the foundation offers three independence awards through its Simons Foundation Autism Research Initiative (SFARI), Simons Collaboration on the Global Brain (SCGB) and Simons Collaboration on Plasticity and the Aging Brain (SCPAB).
The FY23 Defense Appropriations Act is anticipated to provide funding for the TSCRP to support innovative, high-impact tuberous sclerosis complex (TSC) research. The managing agent for the anticipated funding opportunities is the CDMRP at the US Army Medical Research and Development Command (USAMRDC).
Overview: The pilot feasibility core of the Developmental Synaptopathies Consortium (DSC) is pleased to announce that it will fund an estimated $40,000 total costs for a pilot project to stimulate additional research through the DSC NIH grant for one of the following disorders: Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Syndrome (PHTS) and Phelan-McDermid Syndrome (PMS). The funding will be coordinated, dispersed and evaluated for progress through the DSC infrastructure.